Patient: Alexander, 50, Russia
Reason for therapy: "Recently, I've been getting tired from frequent flying, and I was having trouble concentrating at work. I decided to try MMSC because of the high workload and the knowledge that it was beneficial."
Therapy: IV MMSC infusion.
Result: "For the first week, I experienced increased drowsiness, then suddenly I stopped feeling tired. This lasted for a couple of weeks, then passed, but my attention and concentration increased. I was able to work more productively. This lasted for eight months. Additionally, my skin stopped drying out in cold climates, I became calmer and more confident, and my joints stopped hurting at the end of long flights."

Patient: Philip, 55, Spain
Reasons for therapy: “I've been suffering from insomnia lately. I also had constant fatigue, decreased concentration, and decreased performance. I had liver problems. My knee was also bothering me.”
Therapy: IV infusion and local injections of MMSC into the knee.
Result: “My sleep has returned to normal; I'm sleeping like a child. My performance and mood have improved, and my fatigue has decreased. My craving for alcohol has significantly decreased. My liver enzymes (ALT, ALP, GGT) have returned to normal. My digestion has improved—I'm able to digest steaks more easily. My knee has stopped swelling and hurting.”

Patient: Victor, 56, Russia
Reasons for therapy: "I've had bronchial asthma since 1994 and a duodenal ulcer. I fly a lot (over 100 times a year), and after a flight, I had a hard time conducting training and seminars."
Therapy: IV MMSC infusion.
Result: "After three intravenous MMSC injections in 2020, my bronchial asthma disappeared and hasn't bothered me for four years. My ulcer has also stopped bothering me. I feel much better. I had my biological age tested – it turned out to be 14 years younger than my passport age. Also, now I don't feel tired after a flight and can easily conduct training."

Patient: Evgeniya, 40, physician, Russia
Reason for therapy: Decreased performance.
Therapy: IV infusion of the exosomal preparation DC-EX-V (250 x 1012 exosomes).
Result: "On the third day after exosome administration, I feel great, have lots of energy, and sleep well—I fall asleep and wake up easily. No facial swelling. During exercise, I have excellent joint mobility and virtually no fatigue. My hearing and voice have also improved."

NEUROLOGY - spinal cord injury
Patient: Vladislav, 21, Russia
Reason for treatment: A car accident involving the thoracic and cervical spine, resulting in a complex fracture of the C3-C6 cervical vertebrae with spinal cord injury. Lower paraplegia (complete loss of motor function and sensation), upper paraparesis (partial loss of motor function and sensation). Surgery was performed to fix the C4-C6 vertebrae.
Cell therapy: 3 intravenous and 1 local injection of DOKAR VITA CELLS donor bone marrow-derived MMSCs, 2 intravenous and 1 local injection of DC-EX exosomes, and DC-EX-N nasal exosomal drops for 2 months.
RESULTS AFTER 3 MONTHS:
- Arm muscle strength has been restored;
- Sensation and movement in the legs have been restored;
- Urination has been restored (prior to treatment, urine was only removed with a catheter);
- Can care for himself (eat, brush his teeth, ride in a wheelchair, open doors);

DIABETES-1
Patient M, 13, Russia
Reasons for therapy: Type 1 diabetes. Daily insulin injections of 65 units. HbA1C 7.9%. Glucose spikes up to 22 (normal 3-6). Constant fatigue and weakness.
Cell therapy: IV MMSC infusion
Results: Stabilization of glucose levels and elimination of spikes. Reduction of daily insulin dosage to 30 units. HbA1C decreased from 7.9 to 6.8%. Improved well-being and performance.

DIABETES-2
Patient Isares, 42, Thailand
Reason for treatment: chronic fatigue, diabetes-2.
Cell therapy: intravenous infusion of MMSCs.
Results: Improved well-being, increased performance, normalization of the CA 19-9 window marker, HbA1c (glycated hemoglobin), and FBS (glucose levels).

DIABETES-2
Patient: Dr. Suthee R., 61, Thailand
Reason for treatment: "Diabetes 2."
Therapy: IV MMSC infusion.
Result: "Before treatment, HbA1c was 6.5%; after 3 months, it was 5.8%. Improved well-being and performance."

DIABETES-2
Patient N, 52, Thailand
Reasons for therapy: Type 2 diabetes. HbA1C 7.2%. Glucose level 202 mg/dL (normal range 70-99). Constant fatigue and weakness.
Cell therapy: IV infusion of 200 million MMSCs on February 7, 2024.
Results: Decreased glucose levels by 22%. HbA1C decreased from 7.2 to 6.1%. Improved well-being and performance. The results lasted for 1 year.

Diabetic nephropathy
Patient Pavel, 43, Russia
Reasons for therapy: Type 2 diabetes. Diabetic nephropathy. Creatinine level - 266 μmol/L.
Cell therapy: IV infusion of 200 million MMSCs on January 12, 2025.
Result: Creatinine level decreased to 217 μmol/L (by 18%) after 16 days. Improved well-being.

NEUROLOGY - spinal cord injury
Patient Nguyen Duc Thinh, 13, Vietnam.
Reasons for treatment: 2022 car accident to the thoracic spine, complex thoracic spine fracture, spinal cord edema from T5 to T12. Displacement of the 7th and 8th thoracic vertebrae, spinal cord hemorrhage, spinal cord compression, and spinal cord injury.
Lower paraplegia (complete loss of motor function and sensation), urinary incontinence, and pulmonary contusion.
Spinal cord decompression surgery and spinal correction using screws and bone grafts were performed.
Cell therapy: Intravenous and local injection of donor bone marrow-derived MMSCs (DOKAR VITA CELLS), intravenous and local injection of the exosomal preparation DC-EX.
Result: After 3 months, sensation in the legs and the urge to urinate returned.
The patient continues exosome treatment.

DIABETES-1
Patient: Eldar, 24, Russia
Reasons for therapy: Type 1 diabetes. Early stages of diabetic nephropathy, retinopathy, and neuropathy. Daily injections of 24 units of insulin. Insulin production was 0.23 (9% of normal), blood glucose was 9 (150% of normal), and HbA1c was 6.37 (120%).
Cell therapy: Three intravenous infusions of 200 million MMSCs, 1 month apart.
Results: Improved well-being and increased performance. Insulin production increased to 1.4 (by 620%), HbA1c decreased. Glucose spikes disappeared.

KNEE JOINT
Patient: Zung, 80, Vietnam
Reason for treatment: Stage 3 knee osteoarthritis for several years. She underwent multiple treatments, including joint injections every 2-3 months, but to no avail.
Cell therapy: local and intravenous BM-MMSC injections, taping.
Result: significant pain reduction within 2 weeks. The results lasted for 1 year.

KNEE JOINT
Patient: Vladimir, 42, Russia.
Reason for treatment: Professional boxer. He suffered from stage 3 post-traumatic osteoarthritis of the knee joints for 5 years. His knee was painful and constantly swollen. He had undergone 4 knee surgeries and was recommended for joint replacement.
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: "My knee stopped swelling and buckling. I can now do squats and jumps on this leg. I no longer feel pain during exercise." The results lasted for 1 year.

KNEE JOINT
Patient: Alexander, 53, Israel
Reason for therapy: "After an injury and surgery, the patient's right knee was bothering him during long walks, while sitting, or while standing. I decided to try MMSC."
Therapy: Local injections of MMSC into the joint.
Result: "The day after the procedure, I felt much better, was able to walk 3 km and sit for 1.5 hours. A year later, I feel well and am pain-free." Seven years later (2024), the results are still there, and I am pain-free.

KNEE JOINT
Patient: Dr. Nikolai, 79, Russia.
Reason for treatment: Stage 3 osteoarthritis, torn menisci. Constant knee pain for four years. I periodically received knee injections 3-4 times a year, but improvement lasted only one month, then had to repeat.
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: About a month after the injection, there was significant improvement – ​​the pain and crunching in my knee disappeared. I began walking normally without limping. The results lasted one year.

ELBOW JOINT
Patient: Mikhail, 52, Russia.
Reason for treatment: "As a result of constant work at the microscope and computer, I developed severe elbow pain. At the clinic, I was diagnosed with epicondylitis. This was interfering with my work and sleep. I underwent treatment—local injections of hormonal and anti-inflammatory medications, PRP—but there was no effect."
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: "Within a week, my pain was practically gone, and I was able to work and sleep normally." The results lasted for one year.

LOW BACK
Patient: Hitomi, 72, Japan
Reasons for treatment: Lumbar osteochondrosis and herniated discs. Lower back pain when bending and walking for more than 5 minutes.
Treatment: Intravenous infusion and local injection of mechenchymal stem cells from bone marrow in combination with Dokar taping.
Results: The next day, she felt better – no pain, and could bend forward. After two weeks, she was able to walk 2 km without pain. Follow-up since 2018 – pain-free.

ICE-HOCKEY
Patient: Denis, 34, hockey, Russia.
Reason for treatment: Professional hockey player, KHL. Knee injury, underwent two surgeries in Germany. Due to the injury and his age, club management did not want to renew his contract.
Cell therapy: two intravenous and one local injection of MMSCs into the knee (200 and 50 million), taping.
Result: "The knee no longer bothers me. Endurance, recovery, and sleep have improved." Club management extended his contract, and Denis played for three more seasons, despite his age.

Burn on the skin
Patient: Alexander, 52, Russia.
Reason for treatment: Burns to the hands.
Therapy: Applications of the exosomal solution DC-EX-S twice daily for two days.
Result: Skin condition improved within two days.

Rosacea
Patient: Elena, 37, Russia.
Reason for treatment: Rosacea.
Therapy: Localized facial injection of MMSC.
Result: "The injections were painless, and there was no swelling or bruising the next day. The rash on my face disappeared. My face became more hydrated. I really like it."

Rosacea
Patient: Ilya, 40, Ukraine.
Reason for treatment: Rosacea.
Therapy: Local injection of MMSC into the face.
Result: "The rash on my face cleared up within a week. The results lasted for two years."